Artificial Intelligence applied to asthma biomedical research: a systematic review

A. Malva, F. Arpinelli, G. Recchia, C. Micheletto, Robert Alexander
{"title":"Artificial Intelligence applied to asthma biomedical research: a systematic review","authors":"A. Malva, F. Arpinelli, G. Recchia, C. Micheletto, Robert Alexander","doi":"10.1183/13993003.congress-2019.pa1482","DOIUrl":null,"url":null,"abstract":"Introduction: A major application of Artificial Intelligence (AI) is to uncover relevant information from big data. This technology could play major roles in medicine, such as identification of new targets, discovery of new molecules, diagnostics, therapy selection, risk prediction and stratifying disease. Aims and Objective: To provide a review of existing algorithms for the application of AI in research and medical management of asthma. Methods: We performed a systematic review of English scientific articles, using the PubMed database, until Dec. 2018. Search terms included AI, machine learning, deep learning in single combination with asthma term. We included papers focused on human asthma, based on machine learning algorithms. Results: We selected 136 papers on 253 found after excluding duplicated and papers which did not meet inclusion criteria. 52 (40%) regarded the application of AI in asthma pathway analysis, phenotype and biomarker identification, 77 (56%) involved AI in asthma diagnosis, early prediction of exacerbations and predicting control, 7 (5%) are related to AI as support to the management and personalization of the treatment. Conclusions: Standard validation method of these technologies has not been established and data used in each work originate from different sources. Hence it is impossible to perform a direct outcome comparison of selected articles for each application. Evidences of AI confirmed proof of concept, but in order to transfer AI to clinical practice a systematic evaluation of properties, effects, and impacts of health technology is needed.","PeriodicalId":228043,"journal":{"name":"Medical education, web and internet","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical education, web and internet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa1482","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: A major application of Artificial Intelligence (AI) is to uncover relevant information from big data. This technology could play major roles in medicine, such as identification of new targets, discovery of new molecules, diagnostics, therapy selection, risk prediction and stratifying disease. Aims and Objective: To provide a review of existing algorithms for the application of AI in research and medical management of asthma. Methods: We performed a systematic review of English scientific articles, using the PubMed database, until Dec. 2018. Search terms included AI, machine learning, deep learning in single combination with asthma term. We included papers focused on human asthma, based on machine learning algorithms. Results: We selected 136 papers on 253 found after excluding duplicated and papers which did not meet inclusion criteria. 52 (40%) regarded the application of AI in asthma pathway analysis, phenotype and biomarker identification, 77 (56%) involved AI in asthma diagnosis, early prediction of exacerbations and predicting control, 7 (5%) are related to AI as support to the management and personalization of the treatment. Conclusions: Standard validation method of these technologies has not been established and data used in each work originate from different sources. Hence it is impossible to perform a direct outcome comparison of selected articles for each application. Evidences of AI confirmed proof of concept, but in order to transfer AI to clinical practice a systematic evaluation of properties, effects, and impacts of health technology is needed.
人工智能在哮喘生物医学研究中的应用:系统综述
导读:人工智能(AI)的一个主要应用是从大数据中发现相关信息。这项技术可以在医学中发挥重要作用,例如识别新靶点、发现新分子、诊断、治疗选择、风险预测和疾病分层。目的与目的:综述人工智能在哮喘研究和医疗管理中的应用。方法:我们使用PubMed数据库对英文科学文章进行了系统回顾,直到2018年12月。搜索词包括人工智能,机器学习,深度学习与哮喘词的单一组合。我们收录了基于机器学习算法的关于人类哮喘的论文。结果:剔除重复和不符合纳入标准的论文后,我们筛选出253篇论文中的136篇。52例(40%)认为人工智能应用于哮喘通路分析、表型和生物标志物鉴定,77例(56%)认为人工智能应用于哮喘诊断、急性加重早期预测和预测控制,7例(5%)认为人工智能支持管理和个性化治疗。结论:这些技术的标准验证方法尚未建立,各工作中使用的数据来源不同。因此,不可能对每个应用程序的选定文章进行直接的结果比较。人工智能的证据证实了概念的证明,但为了将人工智能应用于临床实践,需要对卫生技术的特性、效果和影响进行系统评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信